-
1
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas...
Published 2025-01-01Subjects: “…Isocitrate dehydrogenase-1…”
Get full text
Article